Drug Shortage Report for FRAXIPARINE
| Report ID | 130817 |
| Drug Identification Number | 02450631 |
| Brand name | FRAXIPARINE |
| Common or Proper name | Fraxiparine®(nadroparin calcium injection (0.6 mL)) |
| Company Name | ASPEN PHARMACARE CANADA INC. |
| Market Status | DORMANT |
| Active Ingredient(s) | NADROPARIN CALCIUM |
| Strength(s) | 9500UNIT |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 10 PF Syringe |
| ATC code | B01AB |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2020-12-21 |
| Estimated end date | 2021-04-23 |
| Actual end date | 2021-04-26 |
| Shortage status | Resolved |
| Updated date | 2021-04-27 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2030 BRISTOL CIRCLE, SUITE 201 OAKVILLE, ONTARIO CANADA L6H 0H2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2021-04-27 | English | Compare |
| v8 | 2021-04-26 | French | Compare |
| v7 | 2021-04-26 | English | Compare |
| v6 | 2021-04-21 | French | Compare |
| v5 | 2021-04-21 | English | Compare |
| v4 | 2021-03-22 | French | Compare |
| v3 | 2021-03-22 | English | Compare |
| v2 | 2021-01-04 | French | Compare |
| v1 | 2021-01-04 | English | Compare |
Showing 1 to 9 of 9